Contrasting effects of n-3 and n-6 fatty acids on cyclooxygenase-2 in model systems for arthritis

Lipids. 2009 Oct;44(10):889-96. doi: 10.1007/s11745-009-3347-x. Epub 2009 Sep 26.

Abstract

Cyclooxygenase-2 (COX-2) is intimately involved in symptoms of arthritis while dietary n-3 polyunsaturated fatty acids (PUFA) are thought to be beneficial. In these experiments, using both bovine and human in vitro systems that mimic features of arthritis, we show that the n-3 PUFA eicosapentaenoic acid (EPA) is able to reduce mRNA and protein levels of COX-2. Activity, as assessed through prostaglandin E(2) formation, was also reduced in a dose-dependent manner. These effects of EPA contrasted noticeably with the n-6 PUFA, arachidonic acid. The data provide direct evidence for a molecular mechanism by which dietary n-3 PUFA, such as EPA, can reduce inflammation and, hence, associated symptoms in arthritis.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arthritis / diet therapy*
  • Arthritis / enzymology*
  • Arthritis / pathology
  • Cartilage, Articular / drug effects
  • Cartilage, Articular / enzymology
  • Cartilage, Articular / pathology
  • Cattle
  • Cells, Cultured
  • Cyclooxygenase 2 / biosynthesis
  • Cyclooxygenase 2 / metabolism*
  • Cyclooxygenase 2 Inhibitors / pharmacology
  • Cyclooxygenase 2 Inhibitors / therapeutic use
  • Dietary Fats / pharmacology
  • Dietary Fats / therapeutic use
  • Fatty Acids, Omega-3 / pharmacology*
  • Fatty Acids, Omega-3 / therapeutic use
  • Fatty Acids, Omega-6 / pharmacology*
  • Fatty Acids, Omega-6 / therapeutic use
  • Humans

Substances

  • Cyclooxygenase 2 Inhibitors
  • Dietary Fats
  • Fatty Acids, Omega-3
  • Fatty Acids, Omega-6
  • Cyclooxygenase 2